December 23, 2015
The Chase Group is proud to represent Eli Lilly on the recruitment of a physician to join their Oncology Business Unit. The physician will play a unique dual role in spearheading the Phase III trial of a remarkable compound for bladder cancer while also working closely with the Early Development Team in determining which compounds show the most promise for future advancement. To learn more about The Chase Group’s strength in securing senior leadership talent, contact us at chase@chasegroup.com.